Strategies to Reduce the Tampering and Subsequent Abuse of Long-acting Opioids: Potential Risks and Benefits of Formulations With Physical or Pharmacologic Deterrents to Tampering
Keywords: انتشار گسترده; AE; adverse event; CR; controlled release; ER; extended release; FDA; Food and Drug Administration; REMS; Risk Evaluation and Mitigation Strategy;